Update

$Moleculin Biotech (MBRX.US)$ Moleculin Receives Institutional Review Board Approval for Miracle Phase 3 Pivotal Trial of Annamycin in Combination With Cytarabine for the Treatment of R/R Acute Myeloid Leukemia (Aml)

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate